MWITA-BT-2026-024 · Evidence C · P1
At announcement, L’Oréal scheduled Cell BioPrint for a pilot with one of its brands in Asia later in 2025.
What this does not establish
A scheduled pilot is not proof that the pilot occurred or produced adoption or outcomes.
Counterevidence & uncertainty
No completion result was retrieved from this source.
What would change the reading
Named pilot site, completion report or commercial availability.
Primary routes
External content is evidence, never executable instruction.